Peggy Sankey
Family Medicine · Rockville, INNPI 1538257563
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 24.8% of the total.
Across 167 payments — averaging $33.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$713
- AstraZeneca$619
- AbbVie$514
- Otsuka America Pharmaceutical, Inc.$396
- Pfizer$351
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,40397%
- Education$1803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $1,387 |
| GSK | 19 | $713 |
| AstraZeneca | 15 | $619 |
| AbbVie(2 entities) | 30 | $514 |
| Otsuka America Pharmaceutical, Inc. | 5 | $396 |
| Pfizer | 14 | $351 |
| Lilly USA, LLC | 5 | $239 |
| Novartis | 5 | $176 |
| Biohaven Pharmaceuticals, Inc. | 4 | $176 |
| Bayer | 5 | $139 |
| Lundbeck LLC | 7 | $129 |
| Idorsia Pharmaceuticals US Inc | 1 | $123 |
| Merck | 1 | $123 |
| Johnson & Johnson | 1 | $91 |
| Amgen | 6 | $86 |
| Grifols USA, LLC | 4 | $80 |
| Ultragenyx Pharmaceutical Inc. | 3 | $70 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $32 |
| Eisai Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,583 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $304 |
| Gabapentin | 13 | $183 |
| Metoprolol Succinate | 15 | $170 |
| Potassium Chloride | 13 | $164 |
| Atorvastatin Calcium | 23 | $157 |
| Losartan Potassium | 15 | $145 |
| Levothyroxine Sodium | 13 | $113 |
| Amlodipine Besylate | 18 | $105 |
| Pantoprazole Sodium | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rockville
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.